2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理

2023-11-15 国外皮肤性病相关专家小组(统称) JAMA Dermatol 发表于上海

伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)是一种罕见但可致命的药物过敏反应。本文主要针对DRESS患者的诊断检查、严重程度评估和治疗达成共识。

中文标题:

2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理

英文标题:

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus

发布日期:

2023-11-15

简要介绍:

伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)是一种罕见但可致命的药物过敏反应。本文主要针对DRESS患者的诊断检查、严重程度评估和治疗达成共识。
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3f59b1c003a528f1, title=2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理, enTitle=Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus, guiderFrom=JAMA Dermatol, authorId=0, author=, summary=伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)是一种罕见但可致命的药物过敏反应。本文主要针对DRESS患者的诊断检查、严重程度评估和治疗达成共识。, cover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, journalId=0, articlesId=null, associationId=1324, associationName=国外皮肤性病相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Wed Nov 15 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight" style="color: #222222;">伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)是一种罕见但可致命的药物过敏反应。本文主要针对DRESS患者的诊断检查、严重程度评估和治疗达成共识。</div> </div> <div class="detailsQRWrapper" style="color: #333333;"> <div id="app_detail" class="detailsQR" title="https://m.medlive.cn/guide/1/30369">&nbsp;</div> </div>, tagList=[TagDto(tagId=34299, tagName=DRESS), TagDto(tagId=483387, tagName=伴有嗜酸性粒细胞增多和全身症状的药物反应)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=483387, articleKeyword=伴有嗜酸性粒细胞增多和全身症状的药物反应, articleKeywordNum=6, guiderKeywordId=483387, guiderKeyword=伴有嗜酸性粒细胞增多和全身症状的药物反应, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1250, appHits=37, showAppHits=0, pcHits=65, showPcHits=1213, likes=0, shares=4, comments=1, approvalStatus=1, publishedTime=Wed Nov 22 18:38:00 CST 2023, publishedTimeString=2023-11-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Wed Nov 22 16:26:03 CST 2023, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Sat Jan 06 10:39:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理.pdf)])
2023 国际共识:伴有嗜酸性粒细胞增多和全身症状的成年患者药物反应的管理.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2170344, encodeId=456e21e034419, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d7f1468938, createdName=li98finder, createdTime=Wed Nov 22 21:41:46 CST 2023, time=2023-11-22, status=1, ipAttribution=福建省)]
    2023-11-22 li98finder 来自福建省

    学习一下

    0